CoChat

Tim-3 as a diagnostic and prognostic biomarker of osteosarcoma

Open access
Ge, Wenhui, Li, Jing, Fan, Wenhao, Xu, Delong, Sun, Shangfei · 2017 · Tumor Biology

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Osteosarcoma is the most frequent primary bone tumor that affects adolescents and children. However, diagnostic and prognostic biomarkers for osteosarcoma remain lacking. (Tim-3) T-cell immunoglobulin domain and mucin domain-3, which negatively regulates T cell helper (Th1) cells and affects cytokine expression, has attracted increasing attention due to its critical role in regulating both adaptive and innate immune cells. In this study, we evaluated serum soluble Tim-3 level in osteosarcoma patients to explore its diagnostic and prognostic value for this particular malignancy. Serum soluble Tim-3 level was measured with enzyme-linked immunosorbent assay in 120 osteosarcoma patients, 120 benign bone tumors patients and 120 healthy controls, followed by analysis of the correlation with clinic pathological characteristics. Receiver operating curves, Kaplan-Meier curves, and log-rank analyses as well as Cox proportional hazard models were used to evaluate the diagnostic and prognostic significance. Serum solubleTim-3 level was remarkably elevated in osteosarcoma patients. Osteosarcoma patients with larger tumor size, late stages and distant metastases were accompanied with higher levels of Tim-3. ROC/AUC analysis indicated thatTim-3 served as a reliable marker to distinguish healthy participants from Tim-3 patients. Osteosarcoma patients with higher Tim-3 had relatively lower survival. Multivariate analyses for overall survival revealed that high serum soluble Tim-3 level was an independent prognostic factor for osteosarcoma. Furthermore, Tim-3 levels of CD8+ and CD4+ T cells were elevated in peripheral circulation of osteosarcoma patients. Therefore, It was indicated in our research that elevated serum soluble Tim-3 level might be a novel potential diagnostic and prognostic biomarker for osteosarcoma patients.

Overview

Integrity signals

Registry

Crossref · 10.1177/1010428317715643

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 3

  1. Zhu LB, 2014, Int J Clin Exp Pathol, 7, 3984
  2. Shen P, 2016, Am J Transl Res, 8, 3419
  3. Cheng G, 2015, Int J Clin Exp Pathol, 8, 9452

Cited by

See all 46

Metadata

Authors
Ge, W., Li, J., Fan, W., Xu, D., & Sun, S.
Affiliations
  • People’s Hospital of Rizhao (CN)
  • Department of Orthopedics & Traumatology, Rizhao Hospital of Traditional Chinese Medicine, Rizhao, China
Corresponding author
Sun, Shangfei
Venue
Tumor Biology
Published
2017-07
Volume
39
Issue
7
Pages
101042831771564
ISSN
  • 1010-4283 (ISSN-L)
  • 1423-0380
OpenAlex
W2735051780
Cited by
45
References
30
Citations by year
2026: 3 · 2024: 6 · 2023: 4 · 2022: 9 · 2021: 10 · 2020: 8 · 2019: 2 · 2018: 2 · 2017: 1
FWCI
2.94
Type
journal article
Language
en
Open access
Licence
  • cc-by-nc
  • journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Tumor Biology (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone Tumor Diagnosis and Treatments
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
TIM-3, osteosarcoma, soluble TIM-3, serum biomarkers, diagnostic biomarkers, prognostic factors, overall survival, CD8+ T cells, CD4+ T cells, T cell regulation, bone tumors
MeSH terms
Hepatitis A Virus Cellular Receptor 2, Adolescent, Adult, Female, Humans, Male, Prognosis, Osteosarcoma, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic, Disease-Free Survival

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.